More stories
²ÞËùÇ¿¼é
News Release
Bamlanivimab Granted Emergency Use Authorization For Early COVID-19 Treatment
Bamlanivimab is an investigational monoclonal antibody treatment that has shown promise in treating mild-to-moderate COVID-19 infections.
²ÞËùÇ¿¼é
News Release
FDA Approves Veklury (Remdesivir) for Treatment of Hospitalized COVID-19 Patients
Learn about how the approval may affect the workers' compensation industry.
Auto Physical Damage
News Release
Bosch and ²ÞËùÇ¿¼é Collaborate on New Tool That Provides Repairers with an All-in-One System for Diagnostic Scanning, Calibration and Estimating
Patented ²ÞËùÇ¿¼é Diagnostics system streamlines the collision repair workflow through industry-leading aftermarket scanning and calibration capabilities combined with support for ²ÞËùÇ¿¼é's cloud-based solutions.
Auto Physical Damage
News Release
²ÞËùÇ¿¼é Delivers Game-Changing XR Hands-Free Solution for Collision Repair Facilities
Brought to market in collaboration with Qualcomm Technologies and RealWear, the ²ÞËùÇ¿¼é Intelligent Vision solution will help collision repair facilities streamline the repair workflow.
Auto Physical Damage
News Release
²ÞËùÇ¿¼é Brings Cloud Estimating to the Canadian Market
Comprehensive cloud-based estimating solution streamlines the appraisal process for Canadian automotive insurers and collision repairers and supports proper, safe vehicle repair.
Auto Physical Damage
News Release
²ÞËùÇ¿¼é Announces Enhanced AutocheX Digital Services Through Collaboration with UpdatePromise
New offerings include enhanced CSI surveys, repair status messaging and online reputation management for collision repairers.